Use of cognitive therapy for relapse prevention in chronic depression: Cost-effectiveness study

British Journal of Psychiatry

Volumn 182, Issue MAR., 2003, Pages 221-227

  Scott, Jan ^a   Palmer, Stephen ^b   Paykel, Eugene ^c   Teasdale, John ^d   Hayhurst, Hazel ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; RECURRENCE RISK; RELAPSE; SYMPTOMATOLOGY;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; FEMALE; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 0037335315     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.182.3.221     Document Type: Article

References (34)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington, DC: APA.
2. Beck, A.T., Ward, C. H., Hendelson, M., et al (1961) An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
3. Berndt, E. R., Koran, L. M., Finkelstein, S. N., et al (2000) Lost human capital from early-onset chronic depression. American Journal of Psychiatry, 157, 940-947.
4. British Medical Association & Royal Pharmaceutical Society of Great Britain (1999) British National Formulary. London & Warlingford: BMJ Books & Pharmaceutical Press.
5. Delaney, B. C., Wilson, S., Roberts, L., et al (2000) Cost-effectiveness of initial endoscopy for dyspepsia in patients over age 50 years; a randomised controlled trial in primary care. Lancet, 356, 1965-1969.
6. Depression Guideline Panel (1993) Clinical Practice Guideline, Number 5: Depression in Primary Care, Volume 2: Treatment of Major Depression, AHCPR Publication No. 93-0551, pp. 45-103. Rockville, MD: US Department of Health and Human Services.
7. DeRubeis, R. J., Gelfand, L. A., Tang, T. Z., et al (1999) Medication versus cognitive behaviour therapy for severely depressed out-patients: mega-analysis of four randomised comparisons. American Journal of Psychiatry 156, 1007-1013.
8. Donaghue, J. (1999) Health economics. In Depressive Disorders (eds M. May & N. Sartorius), pp. 454-459. Chichester: John Wiley & Sons.
9. Efron, B. & Tibshirani, R. (1993) An Introduction to the Bootstrap. New York: Chapman and Hall.
10. Elkin, I., Shea, M., Watkins, J., et al (1989) National Institute of Mental Health Treatment of Depression Collaborative Research Programme: general effectiveness of treatment. Archives of General Psychiatry, 46, 971-982.
11. Evans, M., Hollon, S., DeRubeis, R., et al (1992) Differential relapse following cognitive therapy and pharmacotherapy. Archives of General Psychiatry, 49, 802-809.
12. Fava, G. A., Rafanelli, C., Grandi, S., et al (1998) Six year outcome for cognitive behaviour treatment of residual symptoms in major depression. American Journal of Psychiatry, 155, 1443-1445.
13. Gabbard, G. O., Lazar, S.G., Hornberger, J., et al (1997) The economic impact of psychotherapy. American Journal of Psychiatry, 154, 147-155.
14. Greenberg, P. E., Stiglin, L. E., Finkelstein, S. N., et al (1993) The economic burden of depression in 1990. Journal of Clinical Psychiatry, 54, 405-418.
15. Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278-296.
16. Howland, R. H. (1993) Chronic depression. Hospital and Community Psychiatry, 44, 633-639.
17. Johnsson, B. & Bebbington, P. E. (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. British Journal of Psychiatry, 164, 665-673.
18. Knapp, M. & Beecham, J. (1990) Costing mental health services: the client service receipt inventory. Psychological Medicine, 20, 893-908.
19. McCoombs, J., Stimmel, G., Hui, R., et al (2001) The economic impact of treatment on-response in major depressive disorders. In Treatment-Resistant Mood Disorders (eds J. Amsterdam, M. Hornig & A. Nierbenberg), pp. 491-503. Cambridge: Cambridge University Press.
20. Murray, C. J. & Lopez, A. D. (1996) The Global Burden of Disease. A Comprehensive Assessment of Mortality, and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press.
21. Netten, A., Dennet J. & Knight, J. (1999) Unit Costs of Health and Social Care. Canterbury: University of Kent, Personal Social Services Research Unit.
22. Paykel, E. S., Scott, J., Teasdale, J., et al (1999) Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Archives of General Psychiatry, 56, 829-835.
23. Rosenbaum, J. F. & Hylan,T. R. (1999) Costs of depressive disorders: a review. Depressive Disorders, 21, 401-449.
24. Schafer, J. L. (1999) Multiple imputation: a primer. Statistical Methods in Medical Research, 8, 3-15,
25. Scott, A. I. & Freeman, C. P. (1992) Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ, 304, 883-887.
26. Scott, J. (2000) New evidence in the treatment of chronic depression. New England Journal of Medicine, 342, 1518-1520.
27. _, Teasdale, J. D., Paykel, E. S., et al (2000) Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. British Journal of Psychiatry, 177, 440-446.
28. Simon, G. E., Von Korff, M. & Barlow, W. (1995) Health care costs of primary care patients with recognised depression. Archives of General Psychiatry, 52, 850-856.
29. Statistical Solutions (1999) SOLAS for Missing Data Analysis 2.1. Cork: Statistical Solutions.
30. Sturm, R. & Wells, K. B. (1995) How can care for depression become more cost-effective? Journal of the American Medical Association, 273, 51-58.
31. Thompson, S. G. & Barber, J. A. (2000) How should cost data in pragmatic randomised controlled trials be analysed? BMJ, 320, 1197-2000.
32. UK Prospective Diabetes Study Group (1998) Cost-effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ, 317, 720-726.
33. van Hout, B. A., Al, M. J., Gordon, G. S., et al (1994) Costs, effects and C/E-ratios alongside a clinical trial. Health Economics, 3, 309-319.
34. Wells, K. B., Sturm, R., Sherbourne, C. D., et al (1996) Caring for Depression, pp, 121-210, Cambridge, MA: Harvard University Press.